Ministry of Mines advances India's Critical Mineral Mission (See 'Corp Brief') India embraces global partnership in healthcare: Pharma Secy (See 'Corp Brief') CMD, SAIL reflects on resilience, transformation and future readiness at Company's 53rd AGM (See 'Corp Brief') Hindustan Copper introduces Common Uniform for all (See 'Corp Brief') CCI nod to JSW Paints to buy 75% stake in Akzo Nobel (See 'Corp Brief') IBC – If substantial assets or a new line of business is discovered which goes beyond the capacity of the PRAs or where the existing PRAs will not be able to provide value for the same, fresh Form G may be required: IBBI (See 'Legal Desk') CBDT, field offices to undertake Special Campaign 5.0 for swachhata and efficiency (See 'Corp Brief') CCI approves acquisition of Jaiprakash Associates by PNC Infratech (See 'Corp Brief') CCI allows Triumph Composites to buy entire equity of IPM & OC India into Owens-Corning (See 'Corp Brief') Reddy launches Corporate Salary Package & Enhanced Ex-Gratia for Coal India Workforce (See 'Corp Brief') Competition Act - Conduct being indulged into by OP prima facie amounting to imposition of unfair conditions upon dealers by OP in sale of decorative paints, is contravention of Sec 4(2)(a)(i): CCI (See 'Legal Desk') PM inaugurates infra projects worth Rs 40000 Crores in Bihar's Purnea (See 'Corp Brief') India positioned to become world's top automobile manufacturer: Gadkari (See 'Corp Brief') Startup India-DPIIT signs MoU with CarDekho Group to strengthen ecosystem in mobility (See 'Corp Brief') Companies Act - If sale of disputed property was done with a fraudulent intention by concealment of fact qua pending winding up petition by directors qua purchasers, then process u/s 531, 531A, 533, 536(2), 537 of Companies Act is frustrated: HC (See 'Legal Desk') Nation gears up for Swachhata Hi Seva 2025 (See 'Corp Brief') EPFO Officer selected for World Bank - Milken Institute Program (See 'Corp Brief') Centre to promote research and preserve Heritage languages and traditions (See 'Corp Brief') Competition Act - Seller's right to withhold any gains from liquidation arises only when buyer refuses to lift contracted material and did not perform his part of contractual obligations: CCI (See 'Legal Desk') 'National Agriculture Conference - Rabi Abhiyan 2025' to begin in New Delhi today (See 'Corp Brief') A country cannot feel sense of pride if own people do not speak native language: HM (See 'Corp Brief') DFS organises PSB Manthan 2025 (See 'Corp Brief') PMLA - If additional proceeds of crime are unearthed by ED during further investigation, then it can inform CBI for taking further necessary action at their end: SAFEMA (See 'Legal Desk') IICA DG highlights ESG Integration and IBC 3.0 at Corp-Con 2025 (See 'Corp Brief') Prajapati Assumes Charge as Director of All India Institute of Ayurveda (See 'Corp Brief') SEBI - Fact that transactions in particular contract were reversed with same counterparty indicates prior meeting of minds with view to execute reversal trades at pre-determined price: SEBI (See 'Legal Desk') Board to Report what's Right what's Not (See CORP EINSICHT)

Print

India's First Ferret Research Facility dedicated to Nation

Published: Feb 04, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 04, 2025: INDIA'S commitment to cutting-edge biomedical research and innovation took a significant leap forward with the dedication of the nation's first Ferret Research Facility, the launch of the GARBH-INi-DRISHTI data repository, and the execution of a key technology transfer agreement. The events, held at the Translational Health Science and Technology Institute (THSTI) in the NCR Biotech Science Cluster, Faridabad, Haryana, were presided over by Dr. Rajesh Gokhale, Director General, Biotechnology Research and Innovation Council and Secretary, Department of Biotechnology on 3rd Feb 2025.

The newly inaugurated THSTI Ferret Research Facility, a state-of-the-art establishment adhering to the highest biosafety and research standards, marks a pivotal moment in India's fight against infectious and non-communicable diseases. This pioneering facility will serve as a crucial resource for vaccine development, therapeutic testing, and research into emerging infectious diseases, significantly bolstering India's pandemic preparedness strategy and positioning the nation at the forefront of global scientific endeavors.

Dr. Gokhale also launched GARBH-INi-DRISHTI, the DBT Data Repository and Information Sharing Hub at THSTI. This groundbreaking platform, developed under the GARBH-INi program, provides access to an unprecedented wealth of clinical data, images, and biospecimens collected from over 12,000 pregnant women, newborns, and postpartum mothers. As one of South Asia's largest maternal and child health databases, GARBH-INi-DRISHTI will empower researchers worldwide to conduct transformative research aimed at improving maternal and neonatal health outcomes. Its foundation lies in collaborative efforts across India's leading research institutions and hospitals, representing a powerful synergy of expertise.

Furthering the drive to translate research into tangible benefits, THSTI executed a Technology Transfer Agreement with M/s Sundyota Numandis Probioceuticals Pvt. Ltd. This agreement facilitates the commercialization of THSTI's innovative, genetically defined synthetic microbial consortium, Lactobacillus crispatus . Isolated from the reproductive tracts of women enrolled in the GARBH-INi cohort, this consortium holds immense promise for nutraceutical applications, promoting overall health and well-being through targeted microbiome-based interventions.

Prof. GanesanKarthikeyan, Executive Director of THSTI, highlighted the institute's strategic role in shaping India's biotech ecosystem, emphasizing its contributions to fostering a robust environment for research and commercialization.

Dr. Gokhale lauded THSTI's commitment to translational research, recognizing the Ferret Facility as a landmark achievement placing India among select nations with such capabilities. He commended the development of GARBH-INi-DRISHTI, emphasizing its potential to empower researchers nationwide in improving birth outcomes. Dr. Gokhale also underscored the importance of technology transfer agreements in driving the biomanufacturing ecosystem and applauded THSTI's efforts in forging industry partnerships for commercialization. These combined initiatives represent a powerful confluence of scientific advancement, data-driven research, and industry collaboration, propelling India towards a healthier and more prosperous future.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.